Abbey Bolden
Psychiatric/Mental Health · Shelbyville, INNPI 1770114118
Payments from drug & device makers
Across 92 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$457
- Supernus Pharmaceuticals, Inc.$343
- Axsome Therapeutics, Inc.$240
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$214
- Otsuka America Pharmaceutical, Inc.$159
- Corium, LLC$114
- plus $376 from 15 others
What the payments were for
- Food & beverage$1,80795%
- Education$965%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $457 |
| Supernus Pharmaceuticals, Inc. | 8 | $343 |
| Axsome Therapeutics, Inc. | 7 | $240 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $214 |
| Otsuka America Pharmaceutical, Inc. | 4 | $159 |
| Corium, LLC | 14 | $114 |
| Neurocrine Biosciences, Inc. | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Dynavax Technologies Corporation | 2 | $37 |
| Alkermes, Inc. | 1 | $26 |
| Pfizer | 2 | $25 |
| Insulet Corporation | 1 | $24 |
| Bayer | 1 | $17 |
| Amgen | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Novartis | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,903 in reported general payments places this provider in the 70th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 17 | $1,572 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $528 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 16 | $480 |
| Bupropion XlBupropion Hcl | 26 | $477 |
| Hydroxyzine Hcl | 14 | $435 |
| Duloxetine Hcl | 20 | $406 |
| Buspirone Hcl | 24 | $257 |
| Aripiprazole | 16 | $249 |
| Sertraline Hcl | 12 | $245 |
| Trazodone Hcl | 30 | $192 |
| Amitriptyline Hcl | 19 | $178 |
| Quetiapine Fumarate | 12 | $137 |
| Bupropion Hcl SrBupropion Hcl | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Shelbyville
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
- Savannah MullinsClarksville$31K
- Sharon ClevengerFort Wayne$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.